St. Jude Children's Research Hospital: Disrupting Asxl1 Gene Prevents T-Cell Exhaustion, Improving Immunotherapy
October 11, 2024
October 11, 2024
MEMPHIS, Tennessee, Oct. 11 (TNSres) -- St. Jude Children's Research Hospital issued the following news release:
* * *
Scientists at St. Jude Children's Research Hospital and colleagues found that disrupting the Asxl1 gene improves tumor control during immune checkpoint blockade.
* * *
Immunotherapy, using a patient's own immune system to treat disease, has shown promise in some patients with cancer but has not worked in most. New research from . . .
* * *
Scientists at St. Jude Children's Research Hospital and colleagues found that disrupting the Asxl1 gene improves tumor control during immune checkpoint blockade.
* * *
Immunotherapy, using a patient's own immune system to treat disease, has shown promise in some patients with cancer but has not worked in most. New research from . . .